Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Arcadia Biosciences, Inc. | rkda-ex322_6.htm |
| EX-31.2 - EX-31.2 - Arcadia Biosciences, Inc. | rkda-ex312_9.htm |
| EX-31.1 - EX-31.1 - Arcadia Biosciences, Inc. | rkda-ex311_8.htm |
| 10-Q - 10-Q - Arcadia Biosciences, Inc. | rkda-10q_20200331.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Arcadia Biosciences, Inc. (the “Company”), on Form 10-Q for the quarter ended March 31, 2020 (the “Report”), I, Matthew T. Plavan, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
|
|
(1) |
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Dated: May 13, 2020 |
|
/s/ MATTHEW T. PLAVAN |
|
|
|
Matthew T. Plavan |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |